BIOX icon

Bioceres Crop Solutions

4.53 USD
+0.01
0.22%
At close May 15, 4:00 PM EDT
After hours
4.54
+0.01
0.22%
1 day
0.22%
5 days
0.89%
1 month
4.14%
3 months
-6.21%
6 months
-26.58%
Year to date
-32.59%
1 year
-60.61%
5 years
-24.12%
10 years
-52.81%
 

About: Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Employees: 983

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,415% more call options, than puts

Call options by funds: $606K | Put options by funds: $40K

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

2.04% less ownership

Funds ownership: 21.95% [Q3] → 19.91% (-2.04%) [Q4]

10% less funds holding

Funds holding: 48 [Q3] → 43 (-5) [Q4]

30% less capital invested

Capital invested by funds: $109M [Q3] → $76.1M (-$32.5M) [Q4]

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$7
55%
upside
Avg. target
$7
55%
upside
High target
$7
55%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Oppenheimer
Kristen Owen
64% 1-year accuracy
30 / 47 met price target
55%upside
$7
Outperform
Maintained
22 Apr 2025

Financial journalist opinion

Based on 3 articles about BIOX published over the past 30 days

Neutral
Business Wire
6 days ago
Bioceres Crop Solutions to Host Fiscal Third Quarter 2025 Financial Results Conference Call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2025. A press release detailing these results will be issued.
Bioceres Crop Solutions to Host Fiscal Third Quarter 2025 Financial Results Conference Call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time
Neutral
Accesswire
3 weeks ago
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
Neutral
Accesswire
3 weeks ago
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
Neutral
Business Wire
2 months ago
Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions (NASDAQ: BIOX), a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA's assessment of its negligible risk to human health and non-targ.
Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management
Neutral
Business Wire
2 months ago
Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-ØØ412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved t.
Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042
Negative
Seeking Alpha
3 months ago
Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines
Bioceres Crop Solutions Corp. reported a disappointing Q2 2025 with revenues down 24%, driven by Argentina's economic crisis, despite improved international sales. BIOX stock is down 62% year-over-year, and I maintain a Hold rating due to concerns about the company's ability to turn around. The shift to a licensing model for HB4 technology and R&D cuts may improve short-term finances but pose long-term risks.
Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines
Neutral
Seeking Alpha
3 months ago
Bioceres Crop Solutions Corp. (BIOX) Q2 2025 Earnings Call Transcript
Bioceres Crop Solutions Corp. (BIOX) Q2 2025 Earnings Call Transcript
Bioceres Crop Solutions Corp. (BIOX) Q2 2025 Earnings Call Transcript
Neutral
Business Wire
3 months ago
Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal second quarter ended December 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.
Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results
Neutral
Business Wire
3 months ago
Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million, with gross profit of $45 million and adjusted EBITDA of $15 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first ha.
Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations
Neutral
Business Wire
3 months ago
Bioceres Crop Solutions to Host Fiscal Second Quarter 2025 Financial Results Conference Call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal second quarter ended December 31, 2024. A press release detailing these results will b.
Bioceres Crop Solutions to Host Fiscal Second Quarter 2025 Financial Results Conference Call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time
Charts implemented using Lightweight Charts™